Indegene Ltd Analyst Rating
based on 5 analysts
57.14%
Buy
28.57%
Hold
14.29%
Sell
Based on 5 analysts offering long term price targets for Indegene Ltd. An average target of ₹676
Source: S&P Global Market Intelligence
Indegene Ltd Share analysis
Indegene Ltd price forecast by 5 analysts
Upside of11.45%
High
₹750
Target
₹676.00
Low
₹570
Indegene Ltd target price ₹676, a slight upside of 11.45% compared to current price of ₹587.7. According to 5 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Indegene Ltd revenue growth forecast
Expected growth rate Q1, FY2026:0
Forecast
Actual
Including amortisation and stock based compensations
Indegene Ltd EPS growth forecast
EPS estimate Q1, FY2026:0
Forecast
Actual
Source: S&P Global Market Intelligence
Indegene Ltd Performance
Day's Low
Day's High
₹585.1Day's Price Range₹615.0552 Week's Low
52 Week's High
₹470.152-Week Price Range₹736.3
| Returns % | |
| 1 Month Return | -5.36 % |
| 3 Month Return | -12.09 % |
| 1 Year Return | + 6.24 % |
| Market Stats | |
| Previous Close | ₹606.55 |
| Open | ₹608.00 |
| Volume | 4.43L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹14,405.18Cr |
Indegene Ltd Key Statistics
| P/E Ratio | 37.1 |
| PEG Ratio | 9.76 |
| Market Cap | ₹14,405.18 Cr |
| P/B Ratio | 0 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 15.77 |
Indegene Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹14,405.18 Cr | 1.25% | 0.54 | ₹336 Cr | ₹2,589 Cr | |
| BUY | ₹2,516.20 Cr | 26.72% | 0.56 | ₹83 Cr | ₹933 Cr | |
| NA | ₹324.53 Cr | 1.26% | 0.50 | NA | NA | |
| NA | ₹4,596.79 Cr | 240.16% | 0.56 | NA | NA | |
| BUY | ₹30,463.18 Cr | 34.2% | 0.55 | ₹326 Cr | ₹2,694 Cr |
Indegene Ltd Mutual Fund Holdings
About Indegene Ltd
Share Price: ₹587.70 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹14,405.18Cr as of today
Revenue: ₹686.80Cr as on September 2024 (Q3 24)
Net Profit: ₹91.70Cr as on September 2024 (Q3 24)
Listing date: 13 May, 2024
| Organisation | Indegene Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Indegene Ltd
Indegene Wins Deloitte Technology Fast 50 Award - 09 Dec, 2024
Indegene has been recognized as a winner in the HealthTech category at the Deloitte Technology Fast 50 India 2024 Awards for the second consecutive year, celebrating its rapid growth.Carlyle Group Divests Stake in Indegene Ltd - 04 Dec, 2024
CA Dawn Investments, part of Carlyle Group, sold a 4.3% stake in Indegene for ₹636 crore, averaging ₹619.82 per share in the open market.Carlyle Sells Stake, Indegene Shares Decline - 03 Dec, 2024
Carlyle Group sold a 4.3% stake in Indegene for ₹636 crore, reducing its ownership. Following this, Indegene shares dropped over 6% due to a large block deal.CA Dawn Investments to Divest Stake in Indegene - 02 Dec, 2024
CA Dawn Investments plans to sell a 2.9% stake in Indegene Ltd via block deals at ₹615 per share, potentially raising ₹470 crore. Indegene's shares closed at ₹665.00, down 2.45%.Indegene Expands Operations with New Hyderabad Center - 18 Nov, 2024
Indegene has opened a new center in Hyderabad to enhance its global delivery operations. This initiative aims to support the pharma industry's need for innovation and transformation, aligning with Indegene's mission to prepare healthcare organizations for the future through medical expertise and technology.
Insights on Indegene Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 3.79% to 4.82% in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 92.37% to 92.01% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, INDGN stock has moved down by -5.3%
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 2.31% to 1.64% in Sep 2024 quarter
Indegene Ltd Financials
Index Inclusions
Indegene Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 0% | 0.00 | |
| Foreign Institutions | 4.82% | 27.09 | |
| Mutual Funds | 1.64% | ||
| Retail Investors | 92.01% | ||
| Others | 1.53% |
Indegene Ltd Key Indicators
Indegene Ltd Valuation
Indegene Ltd in the last 5 years
Lowest (32.56x)
June 4, 2024
Today (37.10x)
December 19, 2024
Industry (105.00x)
December 19, 2024
Highest (44.81x)
October 1, 2024
Indegene Ltd Earnings and Dividends
Indegene Ltd Earnings Results
Indegene Ltd’s net profit jumped 22.27% since last year same period to ₹91.70Cr in the Q2 2024-2025. On a quarterly growth basis, Indegene Ltd has generated 4.56% jump in its net profits since last 3-months.
Read More about Earnings Results
Indegene Ltd Technicals Summary
Bearish
Neutral
Bullish
Indegene Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Indegene Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Indegene Ltd shares.
Indegene Ltd (INDGN) share price today is ₹587.7
Indegene Ltd is listed on NSE
Indegene Ltd is listed on BSE
- Today’s highest price of Indegene Ltd is ₹615.05.
- Today’s lowest price of Indegene Ltd is ₹585.1.
PE Ratio of Indegene Ltd is 37.1
PE ratio = Indegene Ltd Market price per share / Indegene Ltd Earnings per share
Today’s traded volume of Indegene Ltd(INDGN) is 4.43L.
Today’s market capitalisation of Indegene Ltd(INDGN) is ₹14405.18Cr.
| Indegene Ltd(INDGN | Price |
|---|---|
52 Week High | ₹736.3 |
52 Week Low | ₹470.1 |
Indegene Ltd(INDGN) share price is ₹587.7. It is down -20.18% from its 52 Week High price of ₹736.3
Indegene Ltd(INDGN) share price is ₹587.7. It is up 25.02% from its 52 Week Low price of ₹470.1
| Indegene Ltd(INDGN | Returns |
|---|---|
1 Day Returns | -18.85% |
1 Month Returns | -5.36% |
3 Month Returns | -12.09% |
1 Year Returns | 6.24% |